The Centre for Medicines Research (CMR) International is the most established and reputable source of pharmaceutical industry metrics and trends analysis. Our experience, independence and integrity coupled with our dedication to providing the best possible data, insights and opinions, makes us the partner of choice for the world’s major pharmaceutical innovators. CMR International is distinguished by its ability to collect, validate and analyze industry-wide proprietary R&D performance metrics, using a proven and secure process. This capability enables us to provide partners with readily accessible information designed to maximize the effectiveness and efficiency of their R&D operations. As a result, CMR International is the world’s most authoritative source of R&D performance metrics, facts and trends.
The CMR International performance metrics programs cover every aspect of pharmaceutical R&D. Our programs are ongoing and focused on key issues, with datasets built over 20 years of rigorous development. The datasets have unique depth and historical context to uncover reliable industry trends, set in context against the changing marketplace.
Origin and history
CMR International was created in 1981 as a division of the Association of the British Pharmaceutical Industry (ABPI). CMR International’s initial role was to challenge public policy and regulatory issues that could adversely affect drug development. Early success, for example in amending long-term study requirements, placed CMR International at the center of pharmaceutical analysis and reform.
In the 1990s, in partnership with the world’s leading pharmaceutical R&D organizations, CMR International pioneered the development of reliable approaches to benchmarking pharmaceutical R&D.
In 2002, CMR International became a fully-independent, private company that was acquired by Thomson Reuters IP & Science division in 2006. The IP & Science Division of Thomson Reuters was divested in 2016 under private equity ownership and rebranded as Clarivate Analytics, a standalone entity. CMR International is a wholly owned subsidiary of Clarivate Analytics. Since 2016, CMR International has been headed by Jamie Munro, Global Practice Leader, Portfolio and Licensing.
We continue to collaborate with the independent, not-for-profit organization Centre for Innovation in Regulatory Science (CIRS). CIRS is the vehicle through which pharmaceutical companies, regulatory authorities, HTAs (Health Technology Assessments) and academia meet, debate and develop regulatory policy.
Mission and values
CMR International’s reputation depends entirely on the value and integrity of the information we provide to our long-standing clients. Pharmaceutical companies work with us because produce industry leading metrics that are dependable and our analyses are of the highest quality and integrity.
Our reputation is built on rigorous definitions of benchmarking terms that we have developed and refined in close cooperation with our clients. Our meticulous audit procedures guarantee the integrity of the information we provide to our clients.
At CMR International, we pride ourselves on being professional, approachable and responsive. We also pride ourselves on the absolute confidentiality in which we hold the information our clients share with us.
Work with us
It’s likely you already work with our information, sometimes without knowing it. Our findings and analysis are one of the major sources of pharmaceutical industry information quoted in public and academic communications, and by consultants, specialist commentators and the press.
Terms and Conditions